Dongrong Yi

791 total citations
33 papers, 512 citations indexed

About

Dongrong Yi is a scholar working on Infectious Diseases, Molecular Biology and Immunology. According to data from OpenAlex, Dongrong Yi has authored 33 papers receiving a total of 512 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 9 papers in Molecular Biology and 9 papers in Immunology. Recurrent topics in Dongrong Yi's work include SARS-CoV-2 and COVID-19 Research (10 papers), Viral gastroenteritis research and epidemiology (8 papers) and interferon and immune responses (8 papers). Dongrong Yi is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (10 papers), Viral gastroenteritis research and epidemiology (8 papers) and interferon and immune responses (8 papers). Dongrong Yi collaborates with scholars based in China, Canada and United Kingdom. Dongrong Yi's co-authors include Quanjie Li, Shan Cen, Fei Guo, Jianyuan Zhao, Xiaoyu Li, Yongxin Zhang, Zhenlong Liu, Ling Ma, Saisai Guo and Xiaoyu Li and has published in prestigious journals such as Nature Communications, Journal of Virology and International Journal of Molecular Sciences.

In The Last Decade

Dongrong Yi

28 papers receiving 510 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dongrong Yi China	12	210	188	128	95	91	33	512
Viktoria Lytvyn Canada	9	293 1.4×	231 1.2×	154 1.2×	17 0.2×	45 0.5×	10	583
Kerstin Lange‐Grünweller Germany	8	214 1.0×	93 0.5×	62 0.5×	96 1.0×	28 0.3×	10	442
Anna Garbelli Italy	15	505 2.4×	137 0.7×	92 0.7×	34 0.4×	59 0.6×	24	799
Irma Herrera‐Camacho Mexico	12	172 0.8×	114 0.6×	106 0.8×	41 0.4×	89 1.0×	38	510
Long V. Pham Denmark	13	141 0.7×	309 1.6×	39 0.3×	23 0.2×	185 2.0×	23	614
Xingxing Yang China	5	178 0.8×	259 1.4×	213 1.7×	21 0.2×	117 1.3×	7	504
Andong Wu China	9	241 1.1×	462 2.5×	125 1.0×	15 0.2×	66 0.7×	10	689
Zhenlong Liu China	15	326 1.6×	220 1.2×	307 2.4×	26 0.3×	172 1.9×	48	854
Qingjiao Liao China	11	181 0.9×	110 0.6×	76 0.6×	13 0.1×	135 1.5×	17	535
Leila S. Ross United States	12	260 1.2×	146 0.8×	102 0.8×	25 0.3×	110 1.2×	17	724

Countries citing papers authored by Dongrong Yi

Since Specialization

Citations

This map shows the geographic impact of Dongrong Yi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongrong Yi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongrong Yi more than expected).

Fields of papers citing papers by Dongrong Yi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dongrong Yi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongrong Yi. The network helps show where Dongrong Yi may publish in the future.

Co-authorship network of co-authors of Dongrong Yi

This figure shows the co-authorship network connecting the top 25 collaborators of Dongrong Yi. A scholar is included among the top collaborators of Dongrong Yi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dongrong Yi. Dongrong Yi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Quanjie, et al.. (2025). Thonningianin A disrupts pA104R−DNA binding and inhibits African swine fever virus replication. Emerging Microbes & Infections. 14(1). 2482697–2482697. 2 indexed citations

Chen, Shumin, Ling Ma, Zhen Wang, et al.. (2025). SLFN14 functions as a P-TEFb inhibitor to modulate the transcription of HIV-1 and cellular genes. Science Advances. 11(51). eadt7982–eadt7982.

Sun, Shihui, Tingting Sun, Xinyu Lei, et al.. (2025). Neferine inhibits Zika virus replication by targeting viral protease. Phytomedicine. 146. 157105–157105.

Zhao, Jian‐Yuan, Guoning Zhang, Yasheng Li, et al.. (2025). Discovery and optimization of phenazopyridine hydrochloride as novel SARS-CoV-2 RdRp inhibitors. European Journal of Medicinal Chemistry. 288. 117422–117422.

Liu, Yang, et al.. (2024). CX-6258 hydrochloride hydrate: A potential non-nucleoside inhibitor targeting the RNA-dependent RNA polymerase of norovirus. Virology. 595. 110088–110088. 1 indexed citations

Zhou, Rui, Qixin Wang, Tingting Zhang, et al.. (2024). Immunogenicity and effectiveness of an mRNA therapeutic vaccine for HPV-related malignancies. Life Science Alliance. 7(6). e202302448–e202302448. 7 indexed citations

Yi, Dongrong, Jing Wang, Qian Liu, et al.. (2024). Protection efficacy of mRNA-based SARS-CoV-2 variant vaccine in non-human primates. Acta Pharmaceutica Sinica B. 15(2). 934–946.

Wang, Lidan, Rui Zhou, Yitong Liu, et al.. (2023). A cell-based assay to discover inhibitors of Zika virus RNA-dependent RNA polymerase. Virology. 589. 109939–109939.

Zhao, Jianyuan, Jing Wang, Xu Pang, et al.. (2022). An anti-influenza A virus microbial metabolite acts by degrading viral endonuclease PA. Nature Communications. 13(1). 2079–2079. 42 indexed citations

10.

Li, Quanjie, Ni An, Yin Xiao, et al.. (2022). MxB Disrupts Hepatitis C Virus NS5A–CypA Complex: Insights From a Combined Theoretical and Experimental Approach. Frontiers in Microbiology. 13. 849084–849084. 4 indexed citations

11.

An, Ni, Quanjie Li, Fei Guo, et al.. (2022). Interferon-inducible SAMHD1 restricts viral replication through downregulation of lipid synthesis. Frontiers in Immunology. 13. 1007718–1007718. 9 indexed citations

12.

Zhang, Zixiong, Ning Zhang, Qian Liu, et al.. (2022). The Zinc-Finger protein ZCCHC3 inhibits LINE-1 retrotransposition. Frontiers in Microbiology. 13. 891852–891852. 1 indexed citations

13.

Zhao, Jian‐Yuan, Dongrong Yi, Quanjie Li, et al.. (2022). 5-Iodotubercidin inhibits SARS-CoV-2 RNA synthesis. Antiviral Research. 198. 105254–105254. 13 indexed citations

14.

Ma, Ling, Quanjie Li, Jian‐Yuan Zhao, et al.. (2022). Repurposing of HIV/HCV protease inhibitors against SARS-CoV-2 3CLpro. Antiviral Research. 207. 105419–105419. 14 indexed citations

15.

Yi, Dongrong, Quanjie Li, Han Wang, et al.. (2022). Repurposing of berbamine hydrochloride to inhibit Ebola virus by targeting viral glycoprotein. Acta Pharmaceutica Sinica B. 12(12). 4378–4389. 19 indexed citations

16.

Guo, Saisai, Xiaobo Lei, Yan Chang, et al.. (2022). SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis. Signal Transduction and Targeted Therapy. 7(1). 400–400. 11 indexed citations

17.

Li, Quanjie, Dongrong Yi, Xiaobo Lei, et al.. (2021). Corilagin inhibits SARS-CoV-2 replication by targeting viral RNA-dependent RNA polymerase. Acta Pharmaceutica Sinica B. 11(6). 1555–1567. 56 indexed citations

18.

Wang, Zhen, Qian Liu, Dongrong Yi, et al.. (2020). HIV-1 resists MxB inhibition of viral Rev protein. Emerging Microbes & Infections. 9(1). 2030–2045. 7 indexed citations

19.

Yi, Dongrong, Quanjie Li, Lili Pang, et al.. (2020). Identification of a Broad-Spectrum Viral Inhibitor Targeting a Novel Allosteric Site in the RNA-Dependent RNA Polymerases of Dengue Virus and Norovirus. Frontiers in Microbiology. 11. 1440–1440. 20 indexed citations

20.

Wang, Jing, Yongxin Zhang, Quanjie Li, et al.. (2019). Influenza Virus Exploits an Interferon-Independent lncRNA to Preserve Viral RNA Synthesis through Stabilizing Viral RNA Polymerase PB1. Cell Reports. 27(11). 3295–3304.e4. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact